T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing

Trends in Molecular Medicine
Coen GoversReno Debets

Abstract

T cell receptor (TCR) gene therapy provides patients with autologous T cells that are genetically engineered with TCRalphabeta chains and constitutes a promising approach for the treatment of tumors and virus infections. Among the current challenges of TCR gene therapy is the optimization of TCRalpha and beta transgene pairing to enhance the functional avidity of therapeutic T cells. Recently, various genetically modified TCRs have been developed that enhance TCR pairing and minimize mispairing, i.e. pairing between transgenic and endogenous TCR chains. Here, we classify such receptors according to their CD3-dependence for surface expression and review their abilities to address functional T cell avidity. In addition, we discuss the anticipated clinical value of these and other strategies to generate high-avidity T cells.

References

Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·S ChungJ L Strominger
Jul 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·P ChamesH R Hoogenboom
Nov 18, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·A SchambachC Baum
Feb 13, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·R J OrentasM I Nishimura
Jan 1, 2003·Cell·Matthew E CallKai W Wucherpfennig
Aug 12, 2003·Human Gene Therapy·Boris EngelsWolfgang Uckert
Sep 16, 2003·Journal of Immunological Methods·Niels SchaftReno Debets
Oct 16, 2003·Protein Engineering·Jonathan M BoulterBent K Jakobsen
Mar 31, 2004·The Journal of Experimental Medicine·Mirjam H M HeemskerkJ H Frederik Falkenburg
Feb 25, 2005·Blood·Karin C StraathofCliona M Rooney
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
Oct 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrizia ComoliSalvatore Siena
Feb 7, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Kirsten B J ScholtenErik Hooijberg
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cor H J LamersEgbert Oosterwijk
Sep 2, 2006·Science·Richard A MorganSteven A Rosenberg
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael H KershawPatrick Hwu
Dec 5, 2006·Cancer Immunology, Immunotherapy : CII·Andreas Hombach, Hinrich Abken
Jul 31, 2007·Blood·Annelies JorritsmaJohn B A G Haanen
Oct 26, 2007·Nature Reviews. Immunology·Matthew E Call, Kai W Wucherpfennig
Dec 7, 2007·The Journal of Clinical Investigation·Carolina BergerStanley R Riddell
Jan 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Elisa KiebackWolfgang Uckert
Sep 12, 2008·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Ralph WillemsenReno Debets
Sep 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
Nov 11, 2008·Nature Medicine·Angel Varela-RohenaJames L Riley

❮ Previous
Next ❯

Citations

Jun 11, 2011·Cancer Causes & Control : CCC·Charlotte S Wilhelm-BenartziCarmen J Marsit
Apr 23, 2010·Human Gene Therapy·Robert E Hawkins ATTACK Consortium
Aug 10, 2010·The Cancer Journal·Richard A MorganSteven A Rosenberg
Feb 10, 2012·American Journal of Physiology. Endocrinology and Metabolism·Nathalie PamirRenée C LeBoeuf
Dec 9, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeremy L DavisRichard A Morgan
Dec 2, 2011·PloS One·Sébastien WälchliJohanna Olweus
Jan 11, 2012·Trends in Molecular Medicine·Vincenzo RussoChiara Bonini
Jan 3, 2012·Seminars in Cancer Biology·Efrat Merhavi-ShohamCyrille J Cohen
Jun 15, 2011·Trends in Biotechnology·Tristen S ParkRichard A Morgan
Jan 18, 2011·Current Opinion in Immunology·Cameron J Turtle, Stanley R Riddell
Mar 22, 2016·Seminars in Immunology·Reno DebetsGeorge Coukos
Oct 12, 2013·European Journal of Immunology·Simone ReußWolfgang Uckert
Jan 21, 2011·Virology·Scott G KitchenDong Sung An
Apr 21, 2016·Current Hematologic Malignancy Reports·Nasheed M HossainRoland B Walter
Feb 23, 2013·Human Vaccines & Immunotherapeutics·Belinda BerdienBoris Fehse
Nov 5, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Trudy StraetemansReno Debets
Jul 20, 2016·Expert Opinion on Biological Therapy·Yi Lin, Hideho Okada
Dec 6, 2017·The Journal of Experimental Medicine·Zinal S ChhedaHideho Okada
Jan 14, 2018·Journal of Hematology & Oncology·Julian A Marin-AcevedoYanyan Lou
Jul 28, 2016·Molecular Medicine·Kangxia HeWei He
May 1, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Astar Haga-FriedmanCyrille J Cohen
Aug 5, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andre KunertReno Debets
Jan 17, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Benita WolfGeorge Coukos
Feb 25, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Munehide NakatsugawaNaoto Hirano
Oct 17, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Coen GoversReno Debets
Mar 17, 2019·Life Science Alliance·Julian J AlbersAngela M Krackhardt
Jun 24, 2020·Cells·Jan A Rath, Caroline Arber
Dec 8, 2019·Nature Biomedical Engineering·Dian KortleveReno Debets
Jun 10, 2017·Current Stem Cell Reports·Juliette M K M Delhove, Waseem Qasim
Jan 23, 2021·Expert Review of Clinical Immunology·Azadehsadat RazaviNima Rezaei
Feb 20, 2021·Nature Reviews. Genetics·Gavin I EllisJames L Riley
Mar 26, 2021·Science Translational Medicine·Yue LiuXin Lin
Jun 3, 2015·Disease Models & Mechanisms·Michaela Sharpe, Natalie Mount
May 30, 2021·Cancer Immunology, Immunotherapy : CII·Jolien VanhoorenTim Lammens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.